WELCOME TO MACIMMUNO
Discover a groundbreaking treatment that leverages gene and cell therapy to transform lives and redefine medical possibilities.
MacImmuno focuses on developing our proprietary gene and cell therapy technology.
We will leverage our expertise in engineering suppressive macrophages to treat asthma.
We will utilize the patient’s own blood cells to develop a personalized, long-lasting, and effective cell therapy.
MacImmuno focuses on developing our proprietary gene and cell therapy technology.
We will leverage our expertise in engineering suppressive macrophages to treat asthma.
We will utilize the patient’s own blood cells to develop a personalized, long-lasting, and effective cell therapy.
Our Technology
CHRONIC DISEASEYou are not alone
We are committed to revolutionizing the treatment of chronic asthma by providing a superior therapy that surpasses the current standard of care.
IMMUONOLOGYMacrophage Immuno Therapy
Our goal is to treat chronic asthma by using a patient's own genetically modified macrophages in which we eliminate the gene responsible for underlying lung chronic modifications.
BENEFITSBreathe easily
This personalized therapy aims to provide long-lasting control over airway inflammation, reduce the frequency and severity of asthma attacks, and minimize the need for systemic medications.
RESULTSIt’s personal
We are dedicated to providing safe, effective, and targeted treatment for asthma. Our approach not only addresses the underlying cause of the condition by reversing its inflammatory process but also focuses on restoring lung function.
ABOUT USWith over 20 years of experience, we guarantee that you will always receive the best possible results.
Our processes will be customized to best suit your case, and we will support you by addressing your inquiries and aiding you in achieving your objectives, improving your quality of life, reducing or eliminating medication, and breathing more easily.
This new therapeutic approach, which has disease-modifying potential, involves treating chronic diseases with engineered macrophages.